PT833626E - Antraquinonas mono- e di-sulfo- substituidas e a sua utilizacao para o tratamento de disturbios da matriz do osso - Google Patents

Antraquinonas mono- e di-sulfo- substituidas e a sua utilizacao para o tratamento de disturbios da matriz do osso

Info

Publication number
PT833626E
PT833626E PT96922001T PT96922001T PT833626E PT 833626 E PT833626 E PT 833626E PT 96922001 T PT96922001 T PT 96922001T PT 96922001 T PT96922001 T PT 96922001T PT 833626 E PT833626 E PT 833626E
Authority
PT
Portugal
Prior art keywords
treatment
bone matrix
pct
antiquarines
sulfo
Prior art date
Application number
PT96922001T
Other languages
English (en)
Inventor
Dino Benetti
Ruggero Aloisi
Giuseppe Guainai
Sergio Rosini
Original Assignee
H Gen B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Gen B V filed Critical H Gen B V
Publication of PT833626E publication Critical patent/PT833626E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT96922001T 1995-06-23 1996-06-17 Antraquinonas mono- e di-sulfo- substituidas e a sua utilizacao para o tratamento de disturbios da matriz do osso PT833626E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001357A IT1276781B1 (it) 1995-06-23 1995-06-23 Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie

Publications (1)

Publication Number Publication Date
PT833626E true PT833626E (pt) 2003-07-31

Family

ID=11371864

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96922001T PT833626E (pt) 1995-06-23 1996-06-17 Antraquinonas mono- e di-sulfo- substituidas e a sua utilizacao para o tratamento de disturbios da matriz do osso

Country Status (16)

Country Link
US (1) US5856358A (pt)
EP (1) EP0833626B1 (pt)
JP (1) JP3307650B2 (pt)
AT (1) ATE233553T1 (pt)
AU (1) AU6303996A (pt)
CA (1) CA2225277A1 (pt)
CZ (1) CZ293326B6 (pt)
DE (1) DE69626514T2 (pt)
DK (1) DK0833626T3 (pt)
ES (1) ES2193248T3 (pt)
IT (1) IT1276781B1 (pt)
MX (1) MX9800049A (pt)
PT (1) PT833626E (pt)
RU (1) RU2202534C2 (pt)
SK (1) SK281853B6 (pt)
WO (1) WO1997000675A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9608133D0 (en) * 1996-04-19 1996-06-26 Gemini International Holdings Diagnostic method and apparatus
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
JPH11236333A (ja) * 1997-12-30 1999-08-31 Pfizer Prod Inc 抗ガン剤として有用なイミダゾリン−４−オン誘導体
US6117869A (en) * 1998-08-04 2000-09-12 Warner-Lambert Company Compounds for and methods of inhibiting matrix metalloproteinases
US6174903B1 (en) 1998-12-28 2001-01-16 Pfizer Inc. Imidazolidin-4-one derivatives useful as anticancer agents
US6610750B1 (en) * 2000-09-15 2003-08-26 Laboratoires Negma Treatment of osteoarthritis
AUPR229600A0 (en) * 2000-12-22 2001-01-25 Commonwealth Scientific And Industrial Research Organisation New oxygen scavenging compositions
US6600057B2 (en) * 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
ES2658964T3 (es) 2007-08-03 2018-03-13 Nucitec S.A. De C.V. Composiciones y métodos para el tratamiento y la prevención de la osteoartritis
EP2504000A1 (en) * 2009-11-24 2012-10-03 The Ohio State University Transcription factor inhibitors and related compositions, formulations and methods
ES2560310T3 (es) * 2010-04-08 2016-02-18 Twi Biotechnology, Inc. Métodos de uso de diacereína como una terapia concomitante para diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2025954A (en) * 1978-07-21 1980-01-30 Ciba Geigy Ag Anthraquinone Sulphonamides
IT1244773B (it) * 1991-03-12 1994-08-08 Gentili Ist Spa N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari

Also Published As

Publication number Publication date
IT1276781B1 (it) 1997-11-03
EP0833626A1 (en) 1998-04-08
WO1997000675A1 (en) 1997-01-09
RU2202534C2 (ru) 2003-04-20
US5856358A (en) 1999-01-05
MX9800049A (es) 1998-11-30
SK281853B6 (sk) 2001-08-06
ITMI951357A1 (it) 1996-12-23
EP0833626B1 (en) 2003-03-05
ES2193248T3 (es) 2003-11-01
ITMI951357A0 (it) 1995-06-23
DE69626514D1 (de) 2003-04-10
JP3307650B2 (ja) 2002-07-24
JPH11509186A (ja) 1999-08-17
CZ293326B6 (cs) 2004-04-14
SK176097A3 (en) 1998-06-03
ATE233553T1 (de) 2003-03-15
CZ419397A3 (cs) 1998-07-15
CA2225277A1 (en) 1997-01-09
DK0833626T3 (da) 2003-06-30
AU6303996A (en) 1997-01-22
DE69626514T2 (de) 2003-12-24

Similar Documents

Publication Publication Date Title
AU697150B2 (en) Use of dioxomorpholines for combating endoparasites, new dioxomorpholines and processes for their preparation
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
AU8772691A (en) New compounds
DE69505542T2 (de) 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten
DE69104723D1 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
PT923933E (pt) Pirazolil-benzenossulfonamidas substituidas para usar no tratamento de inflamacao
PT833626E (pt) Antraquinonas mono- e di-sulfo- substituidas e a sua utilizacao para o tratamento de disturbios da matriz do osso
ES2143666T3 (es) P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales.
PT775143E (pt) Novos derivados de 3h-2,3-benzodiazepina 3-substituidos sua preparacao e utilizacao
DK0668852T3 (da) Substituerede orthoethenylphenyleddikesyrederivater
HRP950437A2 (en) N-substituted azabicycloheptane derivatives, their production and use
BR9510198A (pt) Composto azo pirazolona processo para a sua preparação e utilização do composto
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
KR970701188A (ko) 엔케팔리나제 및 안지오텐신 전환 효소(ACE)의 억제제로서 유용한 신규의 머캅토아세틸아미드 디설파이드 유도체(Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE)
SE9401596D0 (sv) New compounds
FI962301A (fi) Substituoidut aminoalkyyliaminopyridiinit